No Data
No Data
No Data
No Data
No Data
Stifel, Morgan Stanley Bullish on Newly Public Contineum
Seeking AlphaApr 30 13:10 ET
Express News | Contineum Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $29
ReutersApr 30 06:44 ET
Contineum Therapeutics Price Target Announced at $29.00/Share by Stifel
Contineum Therapeutics Price Target Announced at $29.00/Share by Stifel
Dow JonesApr 30 05:30 ET
Contineum Therapeutics Initiated at Overweight by Morgan Stanley
Contineum Therapeutics Initiated at Overweight by Morgan Stanley
Dow JonesApr 30 05:25 ET
Express News | Morgan Stanley Initiates Coverage On Contineum Therapeutics With Overweight Rating, Announces Price Target of $25
BenzingaApr 30 05:15 ET
Contineum Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 58.83% Morgan Stanley → $25 Initiates Coverage On → Overweight
BenzingaApr 30 05:13 ET
No Data
No Data